According to a report by the Japanese news agency on December 12, Japanese actor Murasugi Seminosuke has admitted to allegations of receiving marijuana and other controlled substances on multiple occasions.
Tomokazu Murasugi, whose real name is Tomokazu Murasugi, is 58 years old and resides in Adachi Ward, Tokyo. He has been suspected of receiving marijuana and other drugs multiple times between November last year and January this year.
According to reports, it has been revealed that Villager Sugi came into contact with drug dealers through an online medium and communicated with them using encrypted social networking services. Subsequently, the drugs were received through a mail delivery service. During the investigation into the drug dealers' bank accounts, the police discovered transaction records associated with Sugi.
In the world of theater, Murasugi is a familiar face, having played significant roles in numerous plays and stage productions, including NHK's historical drama series.
After his arrest, Village Sugii's theater group "Otona Keikaku" released a statement on their official website. They stated that they are currently verifying the facts with their lawyer and sincerely apologize to anyone concerned about this matter. They assure that they will promptly address the issue.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
